Common questions about Dezal (FAQ)
Q: What is Dezal actually used for besides the main condition?
A: Regulatory documents indicate that Dezal is approved for the relief of symptoms related to specific allergic conditions. This includes symptoms associated with allergic rhinitis (such as hay fever) and urticaria (hives).
Q: Is Dezal a type of anti-inflammatory drug?
A: Dezal is officially classified as a second-generation antihistamine. While its primary function is to block the histamine receptor, the mechanism of action also involves the modulation of certain downstream inflammatory pathways in the body, which produces an anti-inflammatory effect.
Q: Is it true that Dezal is generally not recommended for people with kidney problems?
A: Dezal's regulatory information notes caution for use in adults with severe renal (kidney) impairment. In these cases, a dosage adjustment to an every-other-day schedule is typically recommended by official guidelines. It is not generally listed as a complete contraindication.
Q: Can people over the age of 65 use Dezal?
A: Dezal is approved for use in all adults, starting at 12 years of age and older. Dosage adjustments are specifically recommended only for adults who have severe renal or hepatic (liver) impairment, not based on age alone.
Q: How long does Dezal stay in your system after you stop taking it?
A: The length of time Dezal remains in the body is determined by its half-life, which is the time it takes for the drug concentration to decrease by half. According to regulatory pharmacokinetic data, the drug's half-life is typically 21 to 27 hours.
Q: Can Dezal be crushed or split if a person has trouble swallowing?
A: The official instructions for the film-coated tablet formulation specify oral intake only. For those who experience difficulty swallowing tablets, alternative dosage forms, such as an oral solution or orally disintegrating tablets (ODT), are generally available.
Q: What is the maximum duration for Dezal use mentioned in official guidelines?
A: There is no specific maximum duration stated for chronic use in official guidelines. The documents indicate that for persistent symptoms, such as in chronic allergic rhinitis or urticaria, continuous treatment may be appropriate during periods of allergen exposure.
Q: Are there any known drug classes that interact with Dezal?
A: Official documents list specific interacting medicines, such as the antifungal drug ketoconazole and the antibiotic erythromycin. These medicines belong to classes, like certain enzyme inhibitors, that can affect how Desloratadine is metabolized by the body.
Q: Does Dezal need time to build up in the body to be effective?
A: Studies show that steady-state plasma concentrations of Desloratadine are typically achieved after approximately 5 once-daily doses. Steady-state is the point where the amount of drug entering the body equals the amount being eliminated.
Q: Is it normal to feel slightly nauseous when first starting Dezal?
A: Nausea is listed in regulatory safety documents as a possible adverse effect. However, it is not among the most frequently reported adverse reactions observed in clinical trials, which commonly list headache, fatigue, and dry mouth.
Q: How does Dezal compare to a placebo in clinical trials?
A: The clinical trials used to gain regulatory approval demonstrated a favorable difference in the relief of symptoms when compared directly to a placebo (an inactive substance).
Q: What is the risk of stopping Dezal suddenly?
A: The regulatory documents for Dezal do not contain warnings or precautions regarding specific risks or discontinuation symptoms associated with suddenly stopping the medication.
Q: Can Dezal affect my mood or cause anxiety?
A: Regulatory safety information lists uncommon or rare adverse reactions that fall under psychiatric or nervous system disorders. These include reports of psychomotor hyperactivity, insomnia, emotional lability, irritability, and other abnormal behaviors.
Q: Is Dezal known to cause weight gain or weight loss?
A: Regulatory safety data has occasionally reported changes in metabolism. These reports have included changes in appetite, such as increased appetite, and a corresponding weight gain.
Q: Does Dezal have a 'black box warning' in the US?
A: The official regulatory labeling for Dezal in the United States does not carry an FDA-mandated Boxed Warning, which is often referred to as a 'black box warning.'
Q: Is it safe to drive or operate machinery while on Dezal?
A: While Dezal is generally non-sedating, official regulatory information recommends determining how one reacts to the medicine before driving or operating machinery. This is because dizziness or somnolence (drowsiness) are listed as possible side effects.
Q: Is there a generic version of Dezal available?
A: Yes, the active ingredient in Dezal, Desloratadine, is now available in multiple generic formulations. These generic versions have received regulatory approval based on their equivalence to the brand-name product.
Q: Does Dezal affect birth control pills?
A: Based on interaction studies performed for regulatory review, Dezal is not listed as having a known interaction with oral contraceptive (birth control) pills.
Q: Does the effectiveness of Dezal change over time?
A: Clinical trial data on chronic use has supported the continuous use of Dezal for persistent symptoms. This evidence suggests that the drug is able to maintain sustained efficacy over a long-term period.
Q: Why does Dezal need to be taken at a certain time of day?
A: The regulatory dosing schedule is once daily. Because the drug has a long half-life of 21–27 hours, it provides 24-hour symptom relief. Therefore, a specific time of day (morning vs. night) is not mandated by the official label.
Q: What kind of experience do real patients report about the first few weeks on Dezal?
A: Regulatory information is based on controlled studies, which report side effects by frequency. The most common adverse reactions experienced by patients in clinical trials are headache, fatigue (tiredness), and dry mouth, which typically occur in the first few weeks of treatment.
Q: Is Dezal a habit-forming or controlled substance?
A: Dezal (Desloratadine) is not classified as a controlled substance under the regulatory schedules in the United States or other international authorities. It is not considered to be habit-forming.
Q: Do studies suggest Dezal improves quality of life?
A: Yes, clinical studies supporting the regulatory approval reported that the relief of allergic symptoms achieved with Dezal was accompanied by general improvements in the patient's overall quality of life.
